The value of color flow doppler ultrasonography of the superior thyroid artery in the surgical management of graves disease

Archives of Surgery

Volumn 138, Issue 2, 2003, Pages 146-151

  Huang, Shih Ming ^a   Chow, Nan Haw ^b   Lee, Hwei Ling ^b   Wu, Ta Jen ^b  

^a TZU CHI UNIVERSITY   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 7;

ADULT; ARTERY; ARTICLE; BLEEDING; BLOOD FLOW VELOCITY; CONTROLLED STUDY; ECHOGRAPHY; FEMALE; GRAVES DISEASE; HISTOPATHOLOGY; HOSPITAL; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MICROVASCULATURE; PRIORITY JOURNAL; SUPERIOR THYROID ARTERY; THYROID GLAND; THYROID WEIGHT; THYROIDECTOMY;

ADULT; FEMALE; GRAVES DISEASE; HEMORRHAGE; HUMANS; MALE; THYROID GLAND; THYROIDECTOMY; ULTRASONOGRAPHY, DOPPLER, COLOR;

EID: 0037321629     PISSN: 00040010     EISSN: None     Source Type: Journal    
DOI: 10.1001/archsurg.138.2.146     Document Type: Article

References (24)

1. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nature Med. 1995;1:27-31.
2. Nagura S, Katoh R, Miyagi E, Shibuya M, Kawaoi A. Expression of vascular endothelial growth factor (VEGF) and VEGF receptor-1 (Flt-1) in Graves disease possibly correlated with increased vascular density. Hum Pathol. 2001;32:10-17.
3. Iitaka M, Miura S, Yamanaka K, et al. increase serum vascular endothedial growth factor levels and intrathyroid vascular area in patients with Graves' disease and Hashimoto's thyroiditis. J Clin Endocrinol Metab. 1998;83:3908-3912.
4. Koda M, Murawaki Y, Kawasaki H. Renovascular resistance assessed by color Doppler ultrasonography in patients with chronic liver disease. J Gastroenterol Hepatol. 2000;15:1424-1429.
5. Grandin CB, Duprez TP, Smith AM, et al. Usefulness of magnetic resonance-derived quantitative measurements of cerebral blood flow and volume in prediction of infarct growth in hyperacute stroke. Stroke. 2001;32:1147-1153.
6. Constant EL, de Volder AG, Ivanoiu A, et al. Cerebral blood flow and glucose metabolism in hypothyroidism: a positron emission tomography study. J Clin Endocrinol Metab. 2001;86:3864-3870.
7. Emoto M, Iwasaki H, Mimura K, Kawarabayashi T, Kikuchi M. Differences in the angiogenesis of benign and malignant ovarian tumors, demonstrated by analyses of color Doppler ultrasound, immunohistochemistry, and microvessel density. Cancer. 1997;80:899-907.
8. Cheng WF, Lee CN, Chu JS, et al. Vascularity index as a novel parameter for the in vivo assessment of angiogenesis in patients with cervical carcinoma. Cancer. 1999;85:651-657.
9. Hodgson KJ, Lazarus JH, Wheeler MH, et al. Duplex scan-derived thyroid blood flow in euthyroid and hyperthyroid patients. World J Surg. 1988;12:470-475.
10. Arntzenius AB, Smit LJ, Schipper J, van der Heide D, Meinders AE. Inverse relation between iodine intake and thyroid blood flow: color Doppler flow imaging in euthyroid humans. J Clin Endocrinol Metab. 1991;73:1051-1055.
11. Ralls PW, Mayekawa DS, Lee KP, et al. Color-flow Doppler sonography in Graves' disease: "thyroid inferno." AJR Am J Roentgenol. 1988;150:781-784.
12. Castagnone D, Rivolta R, Rescalli S, Baldini MI, Tozzi R, Cantalamessa L. Color Doppler sonography in Graves' disease: value in assessing activity of disease and predicting outcome. AJR Am J Roentgenol. 1996;166:203-207.
13. Bogazzi F, Bartalena L, Brogioni S, et al. Color flow doppler sonography rapidly differentiates type I and type II amiodarone-induced thyrotoxicosis. Thyroid. 1997; 7:541-545.
14. Bogazzi F, Bartalena L, Brogioni S, et al. Thyroid vascularity and blood flow are not dependent on serum thyroid hormone levels: studies in vivo by color flow Doppler sonography. Eur J Endocrinol. 1999;140:452-456.
15. Yamamoto A, Dhar DK, El-Assal ON, Igarashi M, Tabara H, Nagasue N. Thymidine phosphorylase (platelet-derived endothelial cell growth factor), microvessel density and clinical outcome in hepatocellular carcinoma. J Hepatol. 1998; 29:290-299.
16. Morosini PP, Simonella G, Mancini V, et al. Color Doppler sonography patterns related to histological findings in Graves' disease. Thyroid. 1998;8:577-582.
17. Alsanea O, Clark OH. Treatment of Graves' disease: the advantages of surgery. Endocrinol Metab Clin North Am. 2000;29:321-337.
18. Soreide JA, van Heerden JA, Lo CY, Grant CS, Zimmerman D, Ilstrup DM. Surgical treatment of Graves' disease in patients younger than 18 years. World J Surg. 1996;20:794-799.
19. Miccoli P, Vitti P, Rago T, et al. Surgical treatment of Graves' disease: subtotal or total thyroidectomy? Surgery. 1996;120:1020-1024.
20. Yamashita H, Murakami T, Nouguchi S, et al. Postoperative tetany in Graves' disease: important role of vitamin D metabolites. Ann Surg. 1999;229:237-245.
21. Chang DC, Wheelwe MH, Woodcock JP, et al. The effect of preoperative Lugol's iodine on thyroid blood flow in patients with Graves' hyperthyroidism Surgery. 1987;102:1055-1061.
22. Ansaldo GL, Pretolesi F, Varaldo E, et al. Doppler evaluation of intrathyroid arterial resistances during preoperative treatment with Lugol's iodide solution in patients with diffuse toxic goiter. J Am Coll Surg. 2000;191:607-612.
23. Yoshida H, Wu MH, Kouchi Y, Onuki Y, Shi O, Sauvage LR. Comparison of the effect of monopolar and bipolar cauterization on skeletonized, dissected internal thoracic arteries. J Thorac Cardiovasc Surg. 1995;110:504-510.
24. Barret E, Guillonneau B, Cathelineau X, Validire P, Vallancien G. Laparoscopic partial nephrectomy in the pig: comparison of three hemostasis techniques. J Endourol. 2001;15:307-312.